Results for 'trial'
MSL Talk: Tom Caravela, Brad Atkinson, Brian Wilson, Christina Wright
How and Why Medical Affairs Can Support Diversity in Clinical Trials
diversity in clinical trials, role of MSLs, FDA guidance on diversity, patient-centric approaches, cultural awareness and allyship
In this episode, Tom Caravela is joined by Brad Atkinson, Brian Wilson, and Christina Wright to explore the critical role of diversity in clinical trials and the MSL’s part in fostering inclusivity. The discussion covers FDA guidance on diversity, challenges in therapeutic areas, and the …
Aug 24th • 42 mins listen
MSL Talk: Tom Caravela, Gail Rosen Spahn
Exploring the MSL role in IITs (Investigator Initiated Trials)
Investigator-Initiated Trials, MSL engagement, KOL engagement, IIT programs, Medical Affairs
In this episode, Gail Rosen Spahn joins to delve into Investigator-Initiated Trials (IITs) and their significance in the MSL landscape. The discussion covers the definition and understanding of IIT programs, the responsibilities of MSLs and investigators, and the role of sales reps. The convers…
Oct 4th • 33 mins listen
MSL Talk: Tom Caravela, Khalil Ahmed
Evolving Role of MSL Field Support for Clinical Trials
Medical Science Liaisons, clinical trials, MSL involvement, Syneos Health, Khalil Ahmed
In this episode, Tom Caravela is joined by Khalil Ahmed to explore the integral role of Medical Science Liaisons (MSLs) in clinical trials. Khalil shares his background and discusses the significant impact MSLs have on site selection, recruitment, and training. The conversation delves into the …
Apr 4th • 34 mins listen
MSL Talk: Tom Caravela, Jeff Vaughn, Dean McAllister
Is it Ever Too Early or Too Late
Medical Science Liaison, drug development, early MSL engagement, clinical trial planning, strategic prioritization
In this episode, Tom Caravela is joined by Jeff Vaughn and Dean McAllister to discuss the critical timing of Medical Science Liaison (MSL) involvement in drug development. They explore misconceptions and historical approaches, highlighting the impact and internal value of early MSL engagement. The c…
Feb 18th • 34 mins listen
Cancer Buzz Podcast
IO Clinical Trials During COVID-19
On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …
Jun 23rd • 13 mins listen
Cancer Buzz Podcast
Improving Community Clinical Trial Participation
Lack of community participation in cancer clinical trials has long been an issue, as has a lack of diversity among participants. On this CANCER BUZZ mini-podcast, learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioriti…
Oct 13th • 6 mins listen
Cancer Buzz Podcast
Increasing Clinical Trial Access for Blood Cancers
Clinical trials are the best instrument to advance treatment for blood cancers, but numerous challenges exist around trial identification, enrollment, and participation. We’ll hear perspectives from a community provider and patient advocacy organization on immediate—and forward-thinkin…
Jun 7th • 19 mins listen
Cancer Buzz Podcast
The Role of the Clinical Trials Navigator
Adding a clinical trials navigator to this practice team required a business case that demonstrated return on investment. After a successful onboarding, this navigator is now the point person to help identify patients appropriate for clinical trials and to help busy clinicians with enrollment crit…
Aug 29th • 6 mins listen
Cancer Buzz Podcast
Clinical Trial Access in Rural Areas
Clinical trials are crucial to cancer research and are often standard of care for patients with cancer, but for patients in rural areas, accessing clinical trials poses significant geographic and financial barriers. On this episode, we learn how Sanford Health harnessed its passion and creativity …
Oct 16th • 24 mins listen
Cancer Buzz Podcast
Advancing Clinical Trial Equity
Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and incl…
Jun 25th • 8 mins listen
Journal of Clinical Oncology (JCO) Podcast
The Importance of Reading Clinical Trial Protocols Simultaneously With Published Studies
This podcast discusses whether the primary outcomes and study design for the reported trial were properly pre-specified and pre-registered prior to accruing participants.
Jan 24th • 12 mins listen
ournal of Clinical Oncology (JCO) Podcast
How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve More Patients?
This podcast considers the impact of exclusion criteria on clinical trials, generalizability, and the complexity of modernizing eligibility while maintaining trial integrity.
Mar 25th • 10 mins listen
Journal of Clinical Oncology (JCO) Podcast
ctDNA in DLBCL: A Blueprint for Better Clinical Trials?
Current clinical characteristics and demographics are not sufficient to capture aggressive disease in clinical trials of newly diagnosed DLBCL. Novel tools, such as measurement of tumor burden via ctDNA, are needed. By : Dr. Matthew Maurer.
Apr 10th • 7 mins listen
Journal of Clinical Oncology (JCO) Podcast
Lack of Gender Equity in Oncology Clinical Trial Advisory Board Membership
Shannon Westin, Pamela Kunz, and Rachna Shroff discuss the lack of gender equity on oncology industry advisory boards.
Nov 25th • 23 mins listen
Journal of Clinical Oncology (JCO) Podcast
Improving Transparency in Phase 1 Clinical Trials
Dr. Shannon Westin and her guests, Dr. Paul Frankel, Dr. Judith Karp, and Dr. Robert Maki discuss how to better inform patients of the risks involved in phase 1 clinical trials.
Feb 9th • 29 mins listen
Journal of Clinical Oncology (JCO) Podcast
Barriers to Clinical Trial Participation for Transgender People
What factors could be excluding transgender people from oncology clinical trials, and what can we do to make them more inclusive? Dr. Westin discusses this important issue with her guests, Dr. Ash Alpert and Dr. Lola Fashoyin-Aje.
Apr 25th • 26 mins listen
Asco Daily News Podcast
How AI Can Improve Patient Identification and Recruitment for Clinical Trials
On today's episode, we will be discussing the promise of artificial intelligence to improve patient recruitment in clinical trials and advanced clinical research. Joining me for this discussion is Dr. Arturo Loaiza-Bonilla, the medical director of oncology research at Capital Health in Philad…
Aug 15th • 19 mins listen
Hematologic Oncology Update Podcast
What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Hodgkin and Non-Hodgkin Lymphomas
Listen on Everand Featuring perspectives from Dr Christopher Flowers and Ms Robin Klebig, moderated by Dr Neil Love. Produced by Research To Practice
Jul 22nd • 62 mins listen
The Oncology Nursing Podcast
The Practical Side of Clinical Trials
ONS member Teresa Knoop, MSN, RN, AOCN®, assistant director of clinical trials at Vanderbilt Ingram Cancer Center in Nashville, TN, joins ONS’s Barbara Lubejko, MS, RN, to discuss the practical side of clinical trials for oncology nursing, including addressing long-term side effects, han…
Sep 18th • 39 mins listen
The Oncology Nursing Podcast
Oncology Clinical Trials and Drug Development
ONS member Moe Schwartz, PharmD, BCOP, professor of pharmacy practice in the James L. Winkle College of Pharmacy at the University of Cincinnati in Ohio and member of the Cincinnati Tri-State ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss cancer drug…
Oct 16th • 38 mins listen